Market revenue in 2023 | USD 776.4 million |
Market revenue in 2030 | USD 1,070.6 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 19.49% in 2023. Horizon Databook has segmented the Asia Pacific point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
The adoption of POC tests is rapidly increasing owing to their associated advantages such as fast, easy, and mobile diagnosis and self-monitoring. These products facilitate diagnosis and monitoring for patients at hospitals, health assessment centers, clinics, and home.
Developing healthcare infrastructure and high prevalence of diabetes are among factors expected to drive the market growth in Asia Pacific countries. Furthermore, rise in adoption of miniaturized models and various measures being taken for reducing stays in hospitals and clinics are expected to boost the demand for POC glucose testing products.
Adoption of POC glucose diagnostics in operating rooms, emergency rooms, intensive care units, path labs, and hospitals is expected to increase owing to early and efficient delivery of results.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific point-of-care glucose testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account